Preferred Label : gilteritinib;
CISMeF synonym : ASP-2215;
MeSH hyponym : ASP2215;
UNII : 66D92MGC8M;
Origin ID : C000609080;
UMLS CUI : C3896940;
ATC code(s)
- Currated CISMeF NLP mapping
- MeSH indexing information
- MeSH term(s) associated for indexing
- Pharmacological action(s)
- Record concept(s)
- See also inter- (CISMeF)
- Semantic type(s)
- UMLS correspondences (same concept)
https://www.has-sante.fr/jcms/p_3192321/fr/xospata
2020
false
false
false
France
gilteritinib
gilteritinib
gilteritinib
administration, oral
insurance, health, reimbursement
treatment outcome
leukemia, myeloid, acute
guidelines for drug use
mutation
leukemia, myeloid, acute
survival analysis
FLT3 Gene Mutation
fms-like tyrosine kinase 3
recurrence
protein kinase inhibitors
protein kinase inhibitors
acute myeloid leukemia with FLT3 mutation
evaluation of the transparency committee
aniline compounds
pyrazines
aniline compounds
pyrazines
---
https://www.ema.europa.eu/en/medicines/human/EPAR/xospata
2019
false
false
false
United Kingdom
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
gilteritinib
gilteritinib
protein kinase inhibitors
protein kinase inhibitors
orphan drug production
adult
antineoplastic agents
antineoplastic agents
leukemia, myeloid, acute
administration, oral
continuity of patient care
FLT3 Gene Mutation
fms-like tyrosine kinase 3
FLT3 protein, human
product surveillance, postmarketing
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
gilteritinib
Tyrosine Kinase Inhibitors
aniline compounds
pyrazines
aniline compounds
pyrazines
---
